MDedge - The investigational fusion protein sotatercept is thought to reduce pulmonary vascular resistance by reversing...
Articles from: MDedge
MDedge - The FDA approved avelumab as maintenance therapy for patients with locally advanced or metastatic urothelial carcinoma that has not progressed with first-line platinum-containing...
MDedge - Dermatology Weekly combines the latest news in clinical dermatology with peer-to-peer interviews with Vincent A. DeLeo, MD. For older Cutis audiocasts, click here....
Higher stroke rates seen among patients with COVID-19 compared with influenza
posted 6 hours
Shared 0 times
MDedge - Clinicians should be vigilant for symptoms and signs of acute ischemic stroke in patients with...
MDedge - Careful diagnosis and management can help avoid unnecessary treatment or...
MDedge - “It makes sense to say that if it makes you uncomfortable to wear a mask because it affects your breathing, you should think twice...
MDedge - Careful diagnosis and management can help avoid unnecessary treatment or...
MDedge - While some outpatient care has rebounded back to prepandemic levels, some ambulatory specialties remain dramatically...
MDedge - Older age was an independent risk factor for postcolonoscopy complications, with individuals older than 75 years having twofold greater odds of complications after...
MDedge - Underrepresented minorities face systemic bias and racism when interacting with the healthcare system, Dr. Salles...
A phase 2 trial of Sotatercept is thought to reduce vascular remodeling and pulmonary vascular resistance for patients with pulmonary arterial hypertension. https://t.co/15ApVmiZyF #ATS2020 https://t.co/15ApVmiZyF